These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 28315122)

  • 21. Cardio-oncology: a multidisciplinary approach for detection, prevention and management of cardiac dysfunction in cancer patients.
    Tajiri K; Aonuma K; Sekine I
    Jpn J Clin Oncol; 2017 Aug; 47(8):678-682. PubMed ID: 28505345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between baseline hemodynamic indices, cardiotoxicity risk, and survival in women with breast cancer.
    Decorads CE; Lambert A; Roch V; Imbert L; Perrin M; Claudin M; Doyen M; Citerne Q; Lamiral Z; Peiffert D; Henneton C; Marie PY
    J Nucl Cardiol; 2024 May; 35():101849. PubMed ID: 38508443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benefits of antihypertensive medications for anthracycline- and trastuzumab-induced cardiotoxicity in patients with breast cancer: Insights from recent clinical trials.
    Rygiel K
    Indian J Pharmacol; 2016; 48(5):490-497. PubMed ID: 27721532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence, time of occurrence and response to heart failure therapy in patients with anthracycline cardiotoxicity.
    Khan AA; Ashraf A; Singh R; Rahim A; Rostom W; Hussain M; Renner I; Collins NJ
    Intern Med J; 2017 Jan; 47(1):104-109. PubMed ID: 27800661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left ventricular strain and strain rates are decreased in children with normal fractional shortening after exposure to anthracycline chemotherapy.
    Moon TJ; Miyamoto SD; Younoszai AK; Landeck BF
    Cardiol Young; 2014 Oct; 24(5):854-65. PubMed ID: 24044518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardioprotective Strategies to Prevent Cancer Treatment-Related Cardiovascular Toxicity: a Review.
    Upshaw JN
    Curr Oncol Rep; 2020 Jun; 22(7):72. PubMed ID: 32564220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Routine first-line detection of breast cancer therapy-related cardiotoxicity by serial, fast and ultra-low-dose equilibrium radionuclide angiography.
    Decorads CE; Lambert A; Roch V; Imbert L; Perrin M; Claudin M; Salleron J; Veran N; Lamiral Z; Henneton C; Marie PY
    J Nucl Cardiol; 2023 Jun; 30(3):1202-1209. PubMed ID: 36289164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trastuzumab and target-therapy side effects: Is still valid to differentiate anthracycline Type I from Type II cardiomyopathies?
    Riccio G; Coppola C; Piscopo G; Capasso I; Maurea C; Esposito E; De Lorenzo C; Maurea N
    Hum Vaccin Immunother; 2016 May; 12(5):1124-31. PubMed ID: 26836985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case of left ventricular assist device application for chemotherapy-related cardiomyopathy caused by trastuzumab and anthracycline.
    Inui T; Kohno H; Matsuura K; Ueda H; Tamura Y; Watanabe M; Inage Y; Yakita Y; Matsumiya G
    J Artif Organs; 2020 Sep; 23(3):270-274. PubMed ID: 31897739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 111Indium-trastuzumab visualises myocardial human epidermal growth factor receptor 2 expression shortly after anthracycline treatment but not during heart failure: a clue to uncover the mechanisms of trastuzumab-related cardiotoxicity.
    de Korte MA; de Vries EG; Lub-de Hooge MN; Jager PL; Gietema JA; van der Graaf WT; Sluiter WJ; van Veldhuisen DJ; Suter TM; Sleijfer DT; Perik PJ
    Eur J Cancer; 2007 Sep; 43(14):2046-51. PubMed ID: 17719768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardio-oncology: cardiovascular complications of cancer therapy.
    Henning RJ; Harbison RD
    Future Cardiol; 2017 Jul; 13(4):379-396. PubMed ID: 28660778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms.
    Rochette L; Guenancia C; Gudjoncik A; Hachet O; Zeller M; Cottin Y; Vergely C
    Trends Pharmacol Sci; 2015 Jun; 36(6):326-48. PubMed ID: 25895646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concepts in cardio-oncology: definitions, mechanisms, diagnosis and treatment strategies of cancer therapy-induced cardiotoxicity.
    Wickramasinghe CD; Nguyen KL; Watson KE; Vorobiof G; Yang EH
    Future Oncol; 2016 Mar; 12(6):855-70. PubMed ID: 26829050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trastuzumab-Induced Cardiotoxicity: When and How Much Should We Worry?
    Zheng H; Mahmood SS; Khalique OK; Zhan H
    JCO Oncol Pract; 2024 Aug; 20(8):1055-1063. PubMed ID: 38662969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Practice Guidelines in Cardio-Oncology.
    Leong DP; Lenihan DJ
    Heart Fail Clin; 2022 Jul; 18(3):489-501. PubMed ID: 35718421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management.
    Curigliano G; Cardinale D; Dent S; Criscitiello C; Aseyev O; Lenihan D; Cipolla CM
    CA Cancer J Clin; 2016 Jul; 66(4):309-25. PubMed ID: 26919165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiotoxicity of cancer chemotherapy in clinical practice.
    Jain D; Aronow W
    Hosp Pract (1995); 2019 Feb; 47(1):6-15. PubMed ID: 30270693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac safety of non-anthracycline trastuzumab-based therapy for HER2-positive breast cancer.
    Yu AF; Mukku RB; Verma S; Liu JE; Oeffinger KC; Steingart RM; Hudis CA; Dang CT
    Breast Cancer Res Treat; 2017 Nov; 166(1):241-247. PubMed ID: 28710537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimizing cardio-oncology programs for cancer patients.
    Francis SA; Asnani A; Neilan T; Scherrer-Crosbie M
    Future Oncol; 2015; 11(14):2011-5. PubMed ID: 26198828
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardio-toxicity among patients with sarcoma: a cardio-oncology registry.
    Shamai S; Rozenbaum Z; Merimsky O; Derakhshesh M; Moshkovits Y; Arnold J; Topilsky Y; Arbel Y; Laufer-Perl M
    BMC Cancer; 2020 Jun; 20(1):609. PubMed ID: 32605637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.